|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.73 GBX | +17.74% |
|
+8.15% | -36.52% |
| Apr. 22 | EARNINGS AND TRADING: Zenova's Kitemark award; Carnival's eyes savings | AN |
| Apr. 18 | Aptamer inks new Optimer+ transplant rejection therapy partnership | AN |
Aptamer Group plc reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was GBP 0.298 million compared to GBP 1.02 million a year ago. Net loss was GBP 1.81 million compared to GBP 2.63 million a year ago.
Basic loss per share from continuing operations was GBP 0.005 compared to GBP 0.0381 a year ago. Diluted loss per share from continuing operations was GBP 0.005 compared to GBP 0.0381 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.52% | 4.27M | |
| +5.85% | 32.93B | |
| +20.16% | 7.94B | |
| +30.81% | 4.19B | |
| -25.95% | 2.8B | |
| -19.96% | 1.38B | |
| -31.87% | 1.17B | |
| +8.02% | 966M | |
| -35.73% | 900M | |
| -25.74% | 839M |
APTAMER GROUP PLC 
